Early and late changes in quality of life following transcatheter aortic valve implantation using the transfemoral and transapical approaches

被引:10
|
作者
Bona, Veronica [1 ]
Khawaja, Muhammed Z. [1 ,2 ]
Bapat, Vinayak [1 ]
Young, Christopher [1 ]
Hancock, Jane [1 ]
Redwood, Simon [1 ,2 ]
Fusari, Melissa [3 ]
Thomas, Martyn [1 ]
机构
[1] Guys & St Thomas NHS Fdn Trust, London SE1 7EH, England
[2] Kings Coll London, Rayne Inst, St Thomas Hosp, BHF Ctr Excellence, London, England
[3] Cardiol Monzino Hosp, Milan, Italy
关键词
aortic valve stenosis; health; quality of life; transapical; transcatheter aortic valve implantation; transfemoral; HIGH-RISK PATIENTS; REPLACEMENT; VALIDITY; STENOSIS; EQ-5D; TAVI;
D O I
10.4244/EIJV11I2A41
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To evaluate the effects of access route upon clinical results and quality of life (QoL) in patients undergoing either transfemoral (TF-TAVI) or transapical balloon-expandable transcatheter aortic valve implantation (TA-TAVI) in the real world. Methods and results: A prospective analysis was performed upon 264 consecutive patients receiving TF-TAVI or TA-TAVI. QoL was assessed using the EQ-5D questionnaire. At baseline, TA-TAVI patients reported significantly more problems in mobility, self-care, usual activities and lower overall health status domains (p<0.01 for all). At 30 days, the TF-TAVI group reported fewer problems with usual activity (p=0.01) and pain/discomfort (p<0.01), and higher EQ-5D index and visual analogue scale (VAS) (p=0.01 and p<0.01, respectively) than the TA-TAVI group. Nevertheless, the absolute improvements (A EQ-5D index and Delta EQ-5D VAS) were larger in the TA-TAVI group, with most dramatically marked QoL absolute improvements (p<0.01 and p=0.02, respectively). By one year, notwithstanding higher all-cause mortality in the sicker TA-TAVI group, there were no differences between groups in any EQ-5D domain. Indeed, surviving TA-TAVI group's greater absolute improvements remained (p<0.01). Conclusions: QoL is greater at the earlier time point of 30 days in the TF-TAVI cohort but equatable by one year. However, the magnitude of improvement in QoL is greater in the TA-TAVI patients at both 30 days and one year.
引用
收藏
页码:221 / 229
页数:9
相关论文
共 50 条
  • [21] Transapical approach for transcatheter aortic valve implantation
    Nakatsuka, Daisuke
    Tabata, Minoru
    ANNALS OF CARDIOTHORACIC SURGERY, 2017, 6 (05) : 553 - 554
  • [22] Factors associated with early cardiac complications following transcatheter aortic valve implantation with transapical approach
    Patris, Vasileios
    Giakoumidakis, Konstantinos
    Argiriou, Mihalis
    Naka, Katerina K.
    Apostolakis, Efstratios
    Field, Mark
    Kuduvalli, Manoj
    Oo, Aung
    Siminelakis, Stavros
    PRAGMATIC AND OBSERVATIONAL RESEARCH, 2018, 9 : 21 - 27
  • [23] PREVALENCE AND IMPACT OF MYOCARDIAL INJURY FOLLOWING TRANSFEMORAL AND TRANSAPICAL TRANSCATHETER AORTIC VALVE REPLACEMENT
    Barbash, Israel
    Ben-Dor, Itsik
    Dvir, Danny
    Corso, Paul
    Boyce, Steven
    Goldstein, Steven
    Wang, Zuyue
    Torguson, Rebecca
    Satler, Lowell
    Pichard, Augusto
    Waksman, Ron
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E5 - E5
  • [24] Early prosthetic valve endocarditis after transfemoral transcatheter aortic valve implantation
    Montero-Cruces, Lourdes
    Luque-Diaz, Tania S.
    Ramchandani-Ramchandani, Bunty
    Carnero-Alcazar, Manuel
    Maroto-Castellanos, Luis
    CIRUGIA CARDIOVASCULAR, 2019, 26 (05): : 229 - 231
  • [25] Is there a difference in outcome and survival after transfemoral vs. transapical transcatheter aortic valve implantation
    Hoti, G.
    Mach, M.
    Pisarik, H.
    Folkmann, S.
    Harrer, M.
    Pollak, J.
    Adlbrecht, C.
    Veit, F.
    Delle Karth, G.
    Grabenwoeger, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 (SUPPL 1) : S46 - S46
  • [26] Health-related quality-of-life after transapical transcatheter aortic valve implantation
    Rex, Christian E.
    Heiberg, Johan
    Klaaborg, Kaj-Erik
    Hjortdal, Vibeke E.
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2016, 50 (5-6) : 377 - 382
  • [27] Is there a difference in outcome and survival after transfemoral vs. transapical transcatheter aortic valve implantation?
    Hoti, G.
    Mach, M.
    Pisarik, H.
    Folkmann, S.
    Harrer, M.
    Pollak, J.
    Adlbrecht, C.
    Veit, F.
    Delle Karth, G.
    Grabenwoeger, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 : S46 - S46
  • [28] Transfemoral transcatheter aortic valve implantation and aortic calcification
    Spartalis, Eleftherios
    Athanasiou, Antonios
    JOURNAL OF CARDIOLOGY, 2018, 71 (5-6) : 597 - 597
  • [29] Transfemoral Compared to Transapical Transcatheter Aortic Valve Implantation in Chronic Dialysis-Dependent Patients
    Mangner, Norman
    Schrader, Manuela
    Haussig, Stephan
    Kiefer, Philipp
    Leontyev, Sergey
    Kappert, Utz
    Alexiou, Konstantin
    Crusius, Lisa
    Erbs, Sandra
    Gasior, Tomasz
    Steul, Jean-Honore
    Goto, Keita
    Trausch, Anne
    Hommel, Jennifer
    Abdel-Wahab, Mohamed
    Borger, Michael A.
    Holzhey, David
    Linke, Axel
    Woitek, Felix J.
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (01)
  • [30] Comparison of early and midterm outcomes after transsubclavian/axillary versus transfemoral, transapical, or transaortic transcatheter aortic valve implantation
    Takagi, Hisato
    Hari, Yosuke
    Nakashima, Kouki
    Kuno, Toshiki
    Ando, Tomo
    HEART & LUNG, 2019, 49 (06): : 519 - 529